Emerging treatment options in the management of non-small cell lung cancer

Pier Luigi Filosso1, Alberto Sandri1, Alberto Oliaro1, Andrea Riccardo Filippi2, Maria Carla Cassinis3, Umberto Ricardi2, Paolo Olivo Lausi1, Sofia Asioli4, Enrico Ruffini11Department of Thoracic Surgery, 2Department of Medical and Surgical Disciplines, Radiation Therapy Division, 3Department of Med...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Filosso PL, Sandri A, Oliaro A, Filippi AR, Cassinis MC, Ricardi U, Lausi P, Asioli S, Ruffini E
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/8cfa451c17894b90843c1be84148d690
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8cfa451c17894b90843c1be84148d690
record_format	dspace
spelling	oai:doaj.org-article:8cfa451c17894b90843c1be84148d6902021-12-02T04:49:45ZEmerging treatment options in the management of non-small cell lung cancer1179-2728https://doaj.org/article/8cfa451c17894b90843c1be84148d6902011-06-01T00:00:00Zhttp://www.dovepress.com/emerging-treatment-options-in-the-management-of-non-small-cell-lung-ca-a7612https://doaj.org/toc/1179-2728Pier Luigi Filosso1, Alberto Sandri1, Alberto Oliaro1, Andrea Riccardo Filippi2, Maria Carla Cassinis3, Umberto Ricardi2, Paolo Olivo Lausi1, Sofia Asioli4, Enrico Ruffini11Department of Thoracic Surgery, 2Department of Medical and Surgical Disciplines, Radiation Therapy Division, 3Department of Medical and Surgical Disciplines, Diagnostic-Imaging Division, 4Department of Oncology and Biomedical Sciences, University of Torino, Torino, ItalyAbstract: Lung cancer (LC) has become the leading cancer-related cause of death in the US and in developed European countries in the last decade. Its incidence is still growing in females and in smokers. Surgery remains the treatment of choice whenever feasible, but unfortunately, many patients have an advanced LC at presentation and one-third of potentially operable patients do not receive a tumor resection because of their low compliance for intervention due to their compromised cardiopulmonary functions and other comorbidities. For these patients the alternative therapeutic options are stereotactic radiotherapy or percutaneous radiofrequency. When surgery is planned, an anatomical resection (segmentectomy, lobectomy, bilobectomy, pneumonectomy, sleeve lobectomy) is usually performed; wedge resection (considered as a nonanatomical one) is generally the accepted option for unfit patients. The recent increase in discovering small and peripheral LCs and/or ground-glass opacities with screening programs has dramatically increased surgeons&#39; interest in limited resections. The role of these resections is discussed. Also, recent improvements in molecular biology techniques have increased the chemotherapic options for neoadjuvant LC treatment. The role and the importance of targeted chemotherapy is also discussed.Keywords: lung cancer, adenocarcinoma, surgery, radiofrequency, radiotherapy, chemotherapyFilosso PLSandri AOliaro AFilippi ARCassinis MCRicardi ULausi PAsioli SRuffini EDove Medical PressarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENLung Cancer: Targets and Therapy, Vol 2011, Iss default, Pp 11-28 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Filosso PL Sandri A Oliaro A Filippi AR Cassinis MC Ricardi U Lausi P Asioli S Ruffini E Emerging treatment options in the management of non-small cell lung cancer
description	Pier Luigi Filosso1, Alberto Sandri1, Alberto Oliaro1, Andrea Riccardo Filippi2, Maria Carla Cassinis3, Umberto Ricardi2, Paolo Olivo Lausi1, Sofia Asioli4, Enrico Ruffini11Department of Thoracic Surgery, 2Department of Medical and Surgical Disciplines, Radiation Therapy Division, 3Department of Medical and Surgical Disciplines, Diagnostic-Imaging Division, 4Department of Oncology and Biomedical Sciences, University of Torino, Torino, ItalyAbstract: Lung cancer (LC) has become the leading cancer-related cause of death in the US and in developed European countries in the last decade. Its incidence is still growing in females and in smokers. Surgery remains the treatment of choice whenever feasible, but unfortunately, many patients have an advanced LC at presentation and one-third of potentially operable patients do not receive a tumor resection because of their low compliance for intervention due to their compromised cardiopulmonary functions and other comorbidities. For these patients the alternative therapeutic options are stereotactic radiotherapy or percutaneous radiofrequency. When surgery is planned, an anatomical resection (segmentectomy, lobectomy, bilobectomy, pneumonectomy, sleeve lobectomy) is usually performed; wedge resection (considered as a nonanatomical one) is generally the accepted option for unfit patients. The recent increase in discovering small and peripheral LCs and/or ground-glass opacities with screening programs has dramatically increased surgeons&#39; interest in limited resections. The role of these resections is discussed. Also, recent improvements in molecular biology techniques have increased the chemotherapic options for neoadjuvant LC treatment. The role and the importance of targeted chemotherapy is also discussed.Keywords: lung cancer, adenocarcinoma, surgery, radiofrequency, radiotherapy, chemotherapy
format	article
author	Filosso PL Sandri A Oliaro A Filippi AR Cassinis MC Ricardi U Lausi P Asioli S Ruffini E
author_facet	Filosso PL Sandri A Oliaro A Filippi AR Cassinis MC Ricardi U Lausi P Asioli S Ruffini E
author_sort	Filosso PL
title	Emerging treatment options in the management of non-small cell lung cancer
title_short	Emerging treatment options in the management of non-small cell lung cancer
title_full	Emerging treatment options in the management of non-small cell lung cancer
title_fullStr	Emerging treatment options in the management of non-small cell lung cancer
title_full_unstemmed	Emerging treatment options in the management of non-small cell lung cancer
title_sort	emerging treatment options in the management of non-small cell lung cancer
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/8cfa451c17894b90843c1be84148d690
work_keys_str_mv	AT filossopl emergingtreatmentoptionsinthemanagementofnonsmallcelllungcancer AT sandria emergingtreatmentoptionsinthemanagementofnonsmallcelllungcancer AT oliaroa emergingtreatmentoptionsinthemanagementofnonsmallcelllungcancer AT filippiar emergingtreatmentoptionsinthemanagementofnonsmallcelllungcancer AT cassinismc emergingtreatmentoptionsinthemanagementofnonsmallcelllungcancer AT ricardiu emergingtreatmentoptionsinthemanagementofnonsmallcelllungcancer AT lausip emergingtreatmentoptionsinthemanagementofnonsmallcelllungcancer AT asiolis emergingtreatmentoptionsinthemanagementofnonsmallcelllungcancer AT ruffinie emergingtreatmentoptionsinthemanagementofnonsmallcelllungcancer
_version_	1718401021025189888

Emerging treatment options in the management of non-small cell lung cancer

Ejemplares similares